Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S (PFE) Price & Analysis

6 Followers

PFE Stock Chart & Stats

C$10.85

C$0.10(0.93%)

Jul 09, 2026

―

Day’s Range― - ―

52-Week RangeC$10.57 - C$12.92

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

C$193.99B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)6.0

Beta0.28

Next Earnings

Aug 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.64

Shares Outstanding5,699,444,300

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S News

Federal health role nominee has record of vaccine skepticism, Stat News reports

Sean Kaufman, who has been nominated to be Assistant Secretary for Preparedness and Response for the Trump administration,...

37s ago

AZN

EBS

Pfizer, Astellas announces FDA approval of PADCEV plus Keytruda in MIBC

Pfizer (PFE) and Astellas Pharma (ALPMY) announced that the U.S. Food and Drug Administration has approved PADCEV, a...

4h ago

MRK

PFE

Pfizer price target lowered to $26 from $27 at BofA

BofA lowered the firm’s price target on Pfizer (PFE) to $26 from $27 and keeps a Neutral rating...

9h ago

PFE

Appeals court upholds win for AstraZeneca in Pfizer patent fight, Reuters says

A U.S. appeals court on Thursday upheld a ruling for AstraZeneca (AZN) against allegations that its blockbuster lung-cancer...

1d ago

AZN

PFE

Pfizer price target lowered to $28 from $30 at JPMorgan

JPMorgan lowered the firm’s price target on Pfizer (PFE) to $28 from $30 and keeps a Neutral rating...

2d ago

PFE

Moderately bullish activity in Pfizer with shares up 1.33%

Moderately bullish activity in Pfizer (PFE), with shares up 32c, or 1.33%, near $24.04. Options volume running well...

3d ago

PFE

Pfizer call volume above normal and directionally bullish

Bullish option flow detected in Pfizer (PFE) with 61,082 calls trading, 1.4x expected, and implied vol increasing over...

3d ago

PFE

Pfizer downgraded to Hold from Buy at HSBC

HSBC downgraded Pfizer (PFE) to Hold from Buy with a price target of $28, down from $32. The...

4d ago

PFE

Moderately bullish activity in Pfizer with shares up 1.7%

Moderately bullish activity in Pfizer (PFE), with shares up 40c, or 1.7%, near $24.29. Options volume roughly in...

8d ago

PFE

Cboe data shows mixed options sentiment in Pfizer with shares down 0.77%

Cboe data shows mixed options sentiment in Pfizer (PFE), with shares down 18c near $23.89. Options volume relatively...

9d ago

PFE

Asad Haider Reiterates Hold on PFE, Keeps 12-Month Price Target Unchanged at $26 Amid CFO Transition and Clinical Upside Uncertainty

In a report released on June 18, Asad Haider from Goldman Sachs maintained a Hold rating on Pfizer,...

19d ago

PFE

Pfizer Obesity Franchise Shows Promise but Competition, Execution Risks Keep Rating at Hold and Price Target Unchanged at $26

Goldman Sachs analyst Asad Haider has maintained their neutral stance on PFE stock, giving a Hold rating on...

1M ago

PFE

Analyst Maintains Hold on Pfizer, Keeps Price Target Unchanged at $27 Amid Pipeline Uncertainties

UBS analyst Michael Yee has maintained their neutral stance on PFE stock, giving a Hold rating on May...

1M ago

PFE

Pfizer Kept at Hold as Oncology Catalyst Nears, Valuation Keeps Price Target Unchanged at $27

UBS analyst Michael Yee has maintained their neutral stance on PFE stock, giving a Hold rating today. Michael...

1M ago

PFE

PFE FAQ

What was Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s price range in the past 12 months?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S lowest stock price was C$10.57 and its highest was C$12.92 in the past 12 months.

What is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s market cap?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s market cap is C$193.99B.

When is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s upcoming earnings report date?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s upcoming earnings report date is Aug 04, 2026 which is in 25 days.

How were Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s earnings last quarter?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S released its earnings results on May 05, 2026. The company reported C$0.643 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.643.

Is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S overvalued?

According to Wall Street analysts Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S pay dividends?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S does not currently pay dividends.

What is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s EPS estimate?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S have?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S has 5,699,444,300 shares outstanding.

What happened to Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s price movement after its last earnings report?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S reported an EPS of C$0.643 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.086%.

Which hedge fund is a major shareholder of Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S?

Currently, no hedge funds are holding shares in TSE:PFE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology